Sierra Oncology is a California-based biopharmaceutical company that develops and commercializes therapies for the treatment of cancer.
Business Model:
Revenue: $300k
Employees: 51-200
Sierra Oncology was acquired by
GlaxoSmithKline.
The acquisition happend on 2022-04-13.
Details of the transaction were not public
Address: 1820 Gateway Drive
City: San Mateo
State: CA
Zip: 94404
Country: US
Sierra Oncology is a California-based biopharmaceutical company that develops and commercializes therapies for the treatment of cancer.
Contact Phone:
+16503768679
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/9/2015
IPO Valuation:
$410M
Ticker Symbol:
SRRA
IPO Price:
$14/share
Amount Raised:
$107M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|